PremiumCompany AnnouncementsOpthea Halts Wet AMD Trials and Cuts Workforce Amid Financial Uncertainty Opthea Announces Major Workforce Reduction Following Trial Setbacks Opthea terminates COAST trial, announces ShORe trial misses endpoint PremiumThe FlyOpthea downgraded to Market Perform from Outperform at Leerink Opthea cut to Market Perform at Leerink on failed sozinibercept trial Opthea double downgraded to Underperform from Buy at Jefferies PremiumRatingsOpthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty Opthea COAST trial misses primary endpoint, enters talks with DFA Investors Opthea Limited Suspends Trading Pending Clinical Trial Results